Cytokine secretion from mononuclear cells cultured in vitro with starch-based polymers and poly-L-lactide

Journal of Biomedical Materials Research - Part A

Volumn 71, Issue 3, 2004, Pages 419-429

  Marques, Alexandra P ^a   Reis, Rui L ^a   Hunt, John A ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Biodegradables; Cytokines; In vitro; Macrophages; Polymers; Starch

Indexed keywords

BIOCHEMISTRY; BIODEGRADATION; CHEMICAL ACTIVATION; IMMUNOLOGY; MICROORGANISMS; STARCH;

ANTIINFLAMMATORY CYTOKINES; IMMUNOREGULATORS; LYMPHOCYTE ACTIVATION;

CELL CULTURE;

CYTOKINE; GAMMA INTERFERON; HYDROXYAPATITE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; POLYLACTIDE; POLYMER; STARCH; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIODEGRADATION; CELL ACTIVATION; CELL CULTURE; CELL DAMAGE; CELL INVASION; COMPOSITE MATERIAL; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CELLS, CULTURED; CYTOKINES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-4; INTERLEUKIN-6; MONOCYTES; POLYESTERS; POLYMERS; STARCH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 8444248693     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30155     Document Type: Article

References (54)

1. Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am 1993;75(6):863-879.
2. Blaine TA, Rosier RN, Puzas JE, Looney RJ, Reynolds PR, Reynolds SD, O'Keefe RJ. Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am 1996;78(8):1181-1192.
3. Konttinen YT, Ju JW, Patiala H, Imai S, Waris V, Li TF, Goodman SB, Nordsletten L, Santavirta S. Cytokines in aseptic loosening of total hip replacement. Curr Orthop 1997;11:40-47.
4. Suzuki K, Onodera S, Matsuno T, Kaneda K, Nishihira J. Identification of macrophage migration inhibitory factor in synovial membranes of loosened total joint replacement. Biochem Mol Biol Int 1996;39(3):529-537.
5. Ninomjya JT, Struve JA, Stelloh CT, Toth JM, Crosby KE. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts. J Orthop Res 2001;19(4):621-628.
6. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145(10):3297-3303.
7. Moldawer LL. Biology of proinflammatory cytokines and their antagonists. Crit Care Med 1994;22(7):S3-7.
8. Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol 2003,111(2 Suppl):S460-475.
9. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 1997;8(4):253-265.
10. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265(3):621-636.
11. Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999;19(2):141-155.
12. Goronzy JJ, Gold KN, Weyand CM. T-cell derived lymphokines as regulators of chronic inflammation: potential targets for immunomodulation? Am J Ther 1996;3(2):109-114.
13. + T cells. Annu Rev Immunol 1994;12:635-673.
14. Young HA, Hardy KJ. Interferon-gamma: producer cells, activation stimuli, and molecular genetic regulation. Pharmacol Ther 1990;45(1):137-151.
15. Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J Leukoc Biol 1995;58(4):373-381.
16. Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN. Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem 1985;260(4):2345-2354.
17. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999;17:331-367.
18. Piazuelo E, Jimenez P, Lanas A, Garcia A, Esteva F, Sainz R. Platelet-derived growth factor and epidermal growth factor play a major role in human colonic fibroblast repair activities. Eur Surg Res 2000;32(3):191-196.
19. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8:253-278.
20. Anderson JM, Miller KM. Biomaterial biocompatibility and the macrophage. Biomaterials 1984;5(1):5-10.
21. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989;86(10):3803-3807.
22. McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995;147(5):1487-1499.
23. Nathan CF, Prendergast TJ, Wiebe ME, Stanley ER, Platzer E, Remold HG, Welte K, Rubin BY, Murray HW. Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med 1984;160(2):600-605.
24. Reis RL, Mendes SC, Cunha AM, Bevis MJ. Processing and in vitro degradation of starch/EVOH thermoplastic blends. Polym Int 1997;43(4):347-352.
25. Malafaya PB, Elvira C, Gallardo A, San Roman J, Reis RL. Porous starch-based drug delivery systems processed by a microwave route. J Biomater Sci Polym Ed 2001;12(11):1227-1241.
26. Gomes ME, Ribeiro AS, Malafaya PB, Reis RL, Cunha AM. A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour. Biomaterials 2001;22(9):883-889.
27. Espigares I, Elvira C, Mano JF, Vázquez B, San Roman J, Reis RL. New partially degradable and bioactive acrylic bone cements based on starch blends and ceramic fillers. Biomaterials 2002;23:1883-1895.
28. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 1992;153(1-2):115-124.
29. Kinneard PR, Gray CD. SPSS for windows: made simple. Hove, UK: Psychology Press; 1999.
30. Marques AP, Reis RL, Hunt JA. The effect of starch-based biomaterials on in vitro leukocyte adhesion and activation. J Mater Sci Mater Med 2004. Forthcoming.
31. DeFife KM, Yun JK, Azeez A, Stack S, Ishihara K, Nakabayashi N, Colton E, Anderson JM. Adhesion and cytokine production by monocytes on poly(2-methacryloyloxyethyl phosphorylcholine-co-alkyl methacrylate)-coated polymers. J Biomed Mater Res 1995;29(4):431-439.
32. Hagerty RD, Salzmann DL, Kleinert LB, Williams SK. Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoroethylene and polyethylene-terephthalate. J Biomed Mater Res 2000;49(4):489-497.
33. Schmidt JA, von Recum AF. Macrophage response to microtextured silicone. Biomaterials 1992;13(15):1059-1069.
34. Wiegand F, Kroncke KD, Kolb-Bachofen V. Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or co-encapsulated erythrocytes. Transplantation 1993;56(5): 1206-1212.
35. Anderson JM. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 1993;2(3):33-41.
36. Bonfield TL, Colton E, Marchant RE, Anderson JM. Cytokine and growth factor production by monocytes/macrophages on protein preadsorbed polymers. J Biomed Mater Res 1992;26(7):837-850.
37. Yun JK, Defife K, Colton E, Stack S, Azeez A, Cahalan L, Verhoeven M, Cahalan P, Anderson JM. Human monocyte-macrophage adhesion and cytokine production on surface-modified poly(tetrafluoroethylene hexafluoropropylene) polymers with and without protein preadsorption. J Biomed Mater Res 1995;29(2):257-268.
38. Boynton EL, Waddell J, Meek E, Labow RS, Edwards V, Santerre JP. The effect of polyethylene particle chemistry on human monocyte-macrophage function in vitro. J Biomed Mater Res 2000;52(2):239-245.
39. Nakaoka R, Tsuchiya T, Nakamura A. Studies on the mechanisms of tumorigenesis induced by polyetherurethane in rats: production of Superoxide, tumor necrosis factor, and interleukin 1 from macrophages cultured on different polyetherurethanes. J Biomed Mater Res 2000;49(1):99-105.
40. Chomyszyn-Gajewska M, Czajkowska B, Blazewicz M, Pamula E, Ptak M. In vitro response of macrophages to a new carbon-polylactide composite for the treatment of periodontal diseases. Biomaterials 2002;23(2):463-470.
41. Ung DY, Woodhouse KA, Sefton MV. Tumor necrosis factor (TNF alpha) production by rat peritoneal macrophages is not polyacrylate surface-chemistry dependent. J Biomed Mater Res 1999;46(3):324-330.
42. Khouw IM, van Wachem PB, de Leij LF, van Luyn MJ. Inhibition of the tissue reaction to a biodegradable biomaterial by monoclonal antibodies to IFN-gamma. J Biomed Mater Res 1998;41(2):202-210.
43. Genassi S, Belardelli F. IFN-γ expression in macrophages and its possible biological significance. Cytokine Growth Factor Rev 1998;9(2):117-123.
44. Scheibenbogen C, Andreesen R. Developmental regulation of the cytokine repertoire in human macrophages: IL-1, IL-6, TNF-alpha, and M-CSF. J Leukoc Biol 1991;50(1):35-42.
45. Bostman OM. Intense granulomatous inflammatory lesions associated with absorbable internal fixation devices made of polyglycolide in ankle fractures. Clin Orthop 1992(278):193-199.
46. Haynes DR, Boyle SJ, Rogers SD, Howie DW, Vernon-Roberts B. Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop 1998(352):223-230.
47. Levings MK, Schrader JW. IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. J Immunol 1999;162(9):5224-5229.
48. Witsell AL, Schook LB. Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation. Proc Natl Acad Sci USA 1992;89(10):4754-4758.
49. Donnelly RP, Crofford LJ, Freeman SL, Buras J, Remmers E, Wilder RL, Fenton MJ. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J Immunol 1993;151(10):5603-5612.
50. Alves CM, Reis RL, Hunt JA. Preliminary study on human protein adsorption and leukocyte adhesion to starch-based biomaterials. J Mater Sci Mater Med 2003;14:157-165.
51. Jaffe WL, Scott DF. Total hip arthroplasty with hydroxyapatite-coated prostheses. J Bone Joint Surg Am 1996;78(12):1918-1934.
52. Geesink R, Hoefnagels N. Eight years results of HA-coated primary total hip replacement. Acta Orthop Belg 1997;63(Suppl 1):72-75.
53. Morscher EW, Hefti A, Aebi U. Severe osteolysis after third-body wear due to hydroxyapatite particles from acetabular cup coating. J Bone Joint Surg Br 1998;80(2):267-272.
54. D'Antonio JA, Capello WN, Manley MT, Feinberg J. Hydroxyapatite coated implants. Total hip arthroplasty in the young patient and patients with avascular necrosis. Clin Orthop 1997;344:124-138.